During the last session, Abeona Therapeutics Inc (NASDAQ:ABEO)’s traded shares were 0.82 million, with the beta value of the company hitting 1.66. At the end of the trading day, the stock’s price was $4.84, reflecting an intraday loss of -0.21% or -$0.01. The 52-week high for the ABEO share is $8.45, that puts it down -74.59 from that peak though still a striking 36.98% gain since the share price plummeted to a 52-week low of $3.05. The company’s market capitalization is $236.19M, and the average intraday trading volume over the past 10 days was 0.95 million shares, and the average trade volume was 477.92K shares over the past three months.
Abeona Therapeutics Inc (ABEO) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. ABEO has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.36.
Abeona Therapeutics Inc (NASDAQ:ABEO) trade information
Abeona Therapeutics Inc (ABEO) registered a -0.21% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.21% in intraday trading to $4.84, hitting a weekly high. The stock’s 5-day price performance is 15.79%, and it has moved by -6.92% in 30 days. Based on these gigs, the overall price performance for the year is -37.63%. The short interest in Abeona Therapeutics Inc (NASDAQ:ABEO) is 2.21 million shares and it means that shorts have 4.84 day(s) to cover.
The consensus price target of analysts on Wall Street is $16, which implies an increase of 69.75% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $16 and $16 respectively. As a result, ABEO is trading at a discount of -230.58% off the target high and -230.58% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 47.21%. While earnings are projected to return 20.86% in 2025, the next five years will return 53.58% per annum.
ABEO Dividends
Abeona Therapeutics Inc is due to release its next quarterly earnings on 2025-Mar-19. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Abeona Therapeutics Inc (NASDAQ:ABEO)’s Major holders
Abeona Therapeutics Inc insiders own 6.59% of total outstanding shares while institutional holders control 68.14%, with the float percentage being 72.95%.
Also, the Mutual Funds coming in first place with the largest holdings of Abeona Therapeutics Inc (ABEO) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 1.23 shares. This amounts to just over 2.53 percent of the company’s overall shares, with a $5.97 million market value. The same data shows that the other fund manager holds slightly less at 678.1, or about 1.39% of the stock, which is worth about $3.28 million.
